Join attorneys on Husch Blackwell’s Psychedelics & Emerging Therapies team for a webinar discussing key factors in conducting clinical trials with psychedelics such as Investigational New Drug applications, site-based risks, DEA licensure, Good Clinical Practice standards, safety issues and trial design. The team will also discuss recent trends in clinical research including alternative trial designs, digital health technology and trial diversity. Finally, we will briefly examine the FDA’s recent Botanical Drug Development guidelines.
Presenters
Kimberly Chew, Attorney
Natasha Sumner, Attorney
Who Should Attend
Hospital business development professionals, C-suite executives, higher education general counsel, researchers, healthcare clinicians, and practitioners interested in or conducting clinical trial work with controlled substances
Continuing Education Credit
This program is pending approval for Colorado, Illinois, Iowa, Kansas, Missouri, Nebraska, Tennessee, Texas and Wisconsin continuing legal education credit.
Did you miss the webinar?
The webinar recording is available after the event date. Simply register using this on-demand link to access the recorded program.